(Q34490398)

English

OCT4 positively regulates Survivin expression to promote cancer cell proliferation and leads to poor prognosis in esophageal squamous cell carcinoma

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

OCT4 positively regulates Survivin expression to promote cancer cell proliferation and leads to poor prognosis in esophageal squamous cell carcinoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

esophageal squamous cell carcinoma

1 reference

based on heuristic

inferred from title

author name string

Chunguang Li

1

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Yan Yan

2

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Weidan Ji

3

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Longlong Bao

4

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Haihua Qian

5

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Lei Chen

6

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Mengchao Wu

7

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Hezhong Chen

8

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Zhigang Li

9

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Changqing Su

10

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

language of work or name

0 references

publication date

21 November 2012

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

e49693

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

copyright license

Creative Commons Attribution 4.0 International

21 November 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Cancer stem cells and novel targets for antitumor strategies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504152

6 July 2018

Overcoming erlotinib resistance in EGFR mutation-positive non-small cell lung cancer cells by targeting survivin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504152

6 July 2018

OCT4 Expression Enhances Features of Cancer Stem Cells in a Mouse Model of Breast Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504152

6 July 2018

Tumor initiating cells in esophageal squamous cell carcinomas express high levels of CD44

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504152

6 July 2018

Survivin silencing as a promising strategy to enhance the sensitivity of cancer cells to chemotherapeutic agents.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504152

6 July 2018

Over-expression of Oct4 in human esophageal squamous cell carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504152

6 July 2018

Inhibition of survivin expression and mechanisms of reversing drug-resistance of human lung adenocarcinoma cells by siRNA.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504152

6 July 2018

Expression of Oct4 in HCC and modulation to wnt/β-catenin and TGF-β signal pathways

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504152

6 July 2018

Survivin as a global target of intrinsic tumor suppression networks

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504152

6 July 2018

Regulation of stem cell pluripotency and differentiation involves a mutual regulatory circuit of the NANOG, OCT4, and SOX2 pluripotency transcription factors with polycomb repressive complexes and stem cell microRNAs.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504152

6 July 2018

Oct3/4 and Sox2 are significantly associated with an unfavorable clinical outcome in human esophageal squamous cell carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504152

6 July 2018

The influence of survivin shRNA on the cell cycle and the invasion of SW480 cells of colorectal carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504152

6 July 2018

Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504152

6 July 2018

Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504152

6 July 2018

Cancer stem cells: the theory and perspectives in cancer therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504152

6 July 2018

Cancer statistics, 2008

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504152

6 July 2018

Survivin: a promising biomarker for detection and prognosis of bladder cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504152

6 July 2018

The universal character of the tumor-associated antigen survivin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504152

6 July 2018

Oct-4 is critical for survival/antiapoptosis of murine embryonic stem cells subjected to stress: effects associated with Stat3/survivin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504152

6 July 2018

Prostate cancer cells with stem cell characteristics reconstitute the original human tumor in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504152

6 July 2018

Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504152

6 July 2018

Survivin: a promising tumor biomarker

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504152

6 July 2018

OCT-4, an embryonic stem cell marker, is highly expressed in bladder cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504152

6 July 2018

Growth factor-dependent regulation of survivin by c-myc in human breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504152

6 July 2018

OCT4: biological functions and clinical applications as a marker of germ cell neoplasia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504152

6 July 2018

Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504152

6 July 2018

Control of developmental regulators by Polycomb in human embryonic stem cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504152

6 July 2018

Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504152

6 July 2018

Transcriptional activation of survivin through the NF-kappaB pathway by human T-cell leukemia virus type I tax.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504152

6 July 2018

Ribozyme-mediated inhibition of survivin expression increases spontaneous and drug-induced apoptosis and decreases the tumorigenic potential of human prostate cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504152

6 July 2018

Stem cell pluripotency and transcription factor Oct4.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504152

6 July 2018

Cell cycle checkpoint signaling: cell cycle arrest versus apoptosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504152

6 July 2018

Expression of survivin in esophageal cancer: correlation with the prognosis and response to chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504152

6 July 2018

Analysis of Oct4-dependent transcriptional networks regulating self-renewal and pluripotency in human embryonic stem cells

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0049693

21 January 2018

Oct4, a novel marker for human gastric cancer.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0049693

21 January 2018

Immunohistochemical analysis of nuclear survivin expression in esophageal squamous cell carcinoma.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0049693

21 January 2018

Overexpression of survivin and cyclin D1 in CHO cells confers apoptosis resistance and enhances growth in serum-free suspension culture

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0049693

21 January 2018

Tumor survivin is downregulated by the antisense oligonucleotide LY2181308: a proof-of-concept, first-in-human dose study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504152

27 October 2018

Multicenter phase II trial of YM155, a small-molecule suppressor of survivin, in patients with advanced, refractory, non-small-cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23185410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of survivin-expressing circulating cancer cells in the peripheral blood of patients with esophageal squamous cell carcinoma and its clinical significance

1 reference

https://pubmed.ncbi.nlm.nih.gov/23185410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preoperative survivin mRNA detection in peripheral blood is an independent predictor of outcome in esophageal carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/23185410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overexpression of p53 and prognosis in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23185410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Skeletonizing en bloc esophagectomy for cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23185410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0049693

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

2012PLoSO...749693L

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34490398&oldid=1866149886"